Bone pain and extremely low bone mineral density due to severe vitamin D deficiency in celiac disease by Rabelink, Noortje M. et al.
CASE REPORT
Bone pain and extremely low bone mineral density due
to severe vitamin D deficiency in celiac disease
Noortje M. Rabelink & Hans M. Westgeest &
Nathalie Bravenboer & Maarten A. J. M. Jacobs &
Paul Lips
Received: 18 April 2011 /Accepted: 20 April 2011 /Published online: 15 June 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract
Case report A 29-year-old wheelchair-bound woman was
presented to us by the gastroenterologist with suspected
osteomalacia. She had lived in the Netherlands all her life
and was born of Moroccan parents. Her medical history
revealed iron deficiency, growth retardation, and celiac
disease, for which she was put on a gluten-free diet. She had
progressive bone pain since 2 years, difficulty with walking,
and about 15kgweightloss. She had a short stature,scoliosis,
and pronounced kyphosis of the spine and poor condition of
her teeth. Laboratory results showed hypocalcemia, an
immeasurableserum25-hydroxyvitaminDlevel,andelevated
parathyroid hormone and alkaline phosphatase levels. Spinal
radiographs showed unsharp, low contrast vertebrae. Bone
mineral density measurement at the lumbar spine and hip
showed a T-score of −6.0 and −6.5, respectively. A bone
scintigraphy showed multiple hotspots in ribs, sternum,
mandible, and long bones. A duodenal biopsy revealed
villous atrophy (Marsh 3C) and positive antibodies against
endomysium, transglutaminase, and gliadin, compatible
with active celiac disease. A bone biopsy showed severe
osteomalacia but normal bone volume. She was treated with
calcium intravenously and later orally. Furthermore, she was
treated with high oral doses of vitamin D and a gluten-free
diet. After a few weeks of treatment, her bone pain decreased,
and her muscle strength improved.
Discussion In this article, the pathophysiology and occur-
rence of osteomalacia as a complication of celiac disease
are discussed. Low bone mineral density can point to
osteomalacia as well as osteoporosis.
Keywords Celiac disease.Osteomalacia.Vitamin D.Bone
mineral density.Histomorphometry
Introduction
Low bone mineral density is the first diagnostic criterion in
patients with osteoporosis. Osteomalacia is however also
characterized by a low BMD. In this article, we will present a
patient referred to our hospital with an extremely low bone
mineral density due to severe osteomalacia with longstanding
celiac disease. It is important to distinguish between osteopo-
rosis and osteomalacia because they differ with regard to
therapy and prognosis.
Case history
A 29-year-old woman of Moroccan origin was admitted to
the Department of Gastroenterology because of refractory
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history revealed growth retardation and iron deficiency
from the age of 6 and the diagnosis of celiac disease at the
age of 17. At the age of 27, there was an ongoing
symptomatic celiac disease despite a gluten-free diet. On
admittance to our hospital, the patient complained of
progressive bone pain over the last 2 years, mainly located
in the ribs, spine, hips, and shoulders. She also had severe
difficultywithwalkingandwasinfactwheelchair-bound.She
was short of breath during normal daily activities and had lost
15 kg in 3 years. She had a regular menstrual cycle, and her
menarche was at 17 years of age. She had neither abdominal
complaints nor diarrhea. On physical examination, she was
pale. Her body height was 148 cm (previously 156 cm) and
herweight,38kg.Shehadbaddentition,andthebackshowed
a scoliosis and pronounced thoracic kyphosis with thoracic
and lumbar percussion pain. Pelvis and shoulders also were
painful on touching. There was muscle atrophy and symmet-
rical loss of proximal muscle strength.
Laboratory evaluation at presentation showed hypocalce-
mia, low serum phosphate, high alkaline phosphatase, and a
serum 25-hydroxyvitamin D (25(OH)D) level below the
detection limit, as shown in Table 1. The serum parathyroid
hormone level was strongly elevated. Furthermore, the
patient had low serum vitamin A (0.9 μmol/L; normal,
1.2–3.0), vitamin B1 (78 nmol/L; normal, 80–160), and
vitamin B6 (6 nmol/L; normal, 13–80) levels. Her serum
folic acid level (30.7 nmol/L; normal, >6) and serum vitamin
B12 level were normal (150 pmol/L; normal, 10–700), and
there were no signs of iron deficiency. At that moment, she
was using the following medications prescribed in the
referring hospital: calcium carbonate 1,000 mg twice daily,
naproxen 500 mg twice daily, pantoprazole 20 mg once
daily, tramadol 50 mg twice daily, ferrioxidesaccharaat
200 mg once a week (intravenous), alfacalcidol 0.5 μgo n c e
daily (intravenous), alendronic acid 70 mg once a week, and
folic acid 5 mg once daily (intravenous).
Radiographs of the thoracic and lumbar spines had a milk
glass appearanceand werenot sharply delineated. The lumbar
vertebrae had a biconcave codfish appearance (Fig. 1a, b)
Bone mineral density measurement (Hologic) showed
extremely low absolute values and T-scores (Table 1). A
skeletal scintigraphy withtechnetium-99 Mshoweda diffusely
elevated uptake in sternum, mandible, and long bones and an
absent kidney sign. There were also multiple symmetric focal
lesions with enhanced uptake in the ribs, compatible with rib
fractures or fissures (Fig. 2a, b). To confirm the clinical diag-
nosis of osteomalacia in this patient with severe refractory
celiac disease and extremely low BMD, a bone biopsy was
obtained from the right iliac crest (Fig. 3a–c). This biopsy
showed a relative osteoid volume of more than 70% and
signs of increased bone turnover compatible with secondary
hyperparathyroidism. The osteoid was covered with high
numbers of active osteoblasts, and resorption lacunae were
filled with multinucleated osteoclasts. Peri-trabecular fibrosis
was also observed. The trabecular bone volume (BV/TV)
was normal, i.e., not compatible with osteoporosis.
This Moroccan young woman with refractory celiac
disease had a very severe osteomalacia with an extremely
low bone mineral density due to a severe vitamin D
deficiency. Treatment with alendronic acid was discontinued,
and the patient was treated during 14 days with intravenous
calcium glubionate up to 8,250 mg (540 mg or 13.5 mmol
Ca
++) daily and oral cholecalciferol 10,000 IU daily. After
these 14 days, her medication consisted of 7 g of calcium
carbonate and 1,200 IU cholecalciferol daily in an outpatient
setting. After the intravenous treatment, the serum 25(OH)D
level increased to 56 nmol/L, and the symptoms of the
patient rapidly improved; the bone pain decreased, muscle
strength and physical performance improved markedly, and
she was able to walk unassisted.
Afterinitiatingoraltreatmentwithcalciumandloweringthe
cholecalciferol dose, there was a gradual decline of 25(OH)D,
and we had to increase the oral dose of cholecalciferol to
10,000 IU a day. Questioning revealed gluten exposure and
patient was given advice repeatedly on how to maintain a strict
gluten-free diet. After raising the oral dose of cholecalciferol,
the serum 25(OH)D levelincreasedto 34nmol/L, andthe 1,25
(OH)vitamin D to >250 pmol/L. Bone mineral density
measurement 5 1/2 months after initiation of therapy showed
a significant increase at the lumbar spine (L1–L4) and hip,
Table 1 Results of laboratory evaluation, BMD measurement and
histomorphometry
Laboratory evaluation Patient Reference values
Calcium 1.94 mmol/L 2.20–2.60 mmol/L
Phosphate 0.71 mmol/L 0.70–1.40 mmol/L
Albumin 35 g/L 35–52 g/L
Alkaline phosphatase 386 U/L <120 U/L
25 hydroxy vitamin D <10 nmol/L 25–150 nmol/L
1,25 hydroxy vitamin D
a 76 pmol/L 50–160 pmol/L
Parathyroid hormone (fasting) 75 pmol/L <11 pmol/L
DXA BMD T-score, Z-score
LWK (L1–L4) 0.390 g/cm² −6.0, −6.0
Hip 0.153 g/cm² −6.5, −6.4
Bone histomorphometry
Trabecular bone volume (%) BV/TV=37.48%
Osteoid (%) OV/BV=75.07%
Trabecular thickness 261 μm
Osteoid thickness 98.5 μm
aAfter initiating vitamin D therapy
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2 (T-score, −5.5) and 0.22 g/cm
2 (T-score, −5.9),
respectively. Further follow-up of this patient was not
possible because she did not respond to multiple invitations
to visit our outpatient clinic.
Fig. 1 Radiographs, lateral view, of the lower thoracic (a) and lumbar
vertebrae (b). Thoracic vertebrae are blurred and lumbar vertebrae
show codfish appearance
Fig. 2 Bone scintigraphy; Whole body, anterior view (a) and detail of
the ribs, lateral view (b). Hot spots may indicate pseudofractures or
fissures
a
b
c
Fig. 3 Crista biopsy; Goldner stain, magnification 5×10 (a), Goldner
stain, magnification 10×10 (b), and Tartrate-resistant acidic phospha-
tase stain, magnification 10×10 (c). Mineralized bone is green and
osteoid tissue, red. Osteoid seems very thick, and osteoid volume is
75%. Bone resorption by multinucleated osteoclasts is increased
(arrows)
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Osteomalacia is seldom described as a complication of
celiac disease and rarely seen as presenting clinical
condition [2, 5, 10]. In our patient, osteomalacia was a
late complication of ongoing celiac disease due to poor
compliance regarding gluten-free diet. Osteomalacia may
occur as a consequence of severe longstanding vitamin D
deficiency when sunshine exposure is very low [10, 24].
Sunshine exposure still is the main source of vitamin D. It
is highly likely that in our patient, a pigmented skin,
covered by clothes, and the northern latitude of the
Netherlands have contributed to the severity of the
osteomalacia. Also, calcium malabsorption causes sec-
ondary hyperparathyroidism, and the latter results in an
enhanced metabolic breakdown of vitamin D metabolites
[3, 4, 14, 19, 22]. Calcium malabsorption in celiac disease
is due to villous atrophy in the proximal intestine. Villous
atrophy causes a reduction of active absorption of calcium
and an increase of unbound intraluminal fatty acids that
bind intraluminal calcium and inhibit absorption. Vitamin
D receptor resistance in the intestinal wall has been
suggested, and the amount of vitamin D-dependent
calcium-binding proteins in the intestinal wall appears to
be reduced in active disease [19]. Other factors could also
reduce bone mineral density, such as secondary amenor-
rhea induced by low body weight [6, 13, 18], lactose
intolerance, immobility [9], inflammation [7, 20], and
antibodies against regulating proteins [17].
Common symptoms of osteomalacia are proximal
muscle weakness, difficulty with walking and especially
climbing stairs, a waddling gait, difficulty with rising out of
a chair, and bone pain [9]. After initiating treatment for
osteomalacia, the symptoms typically disappear within
weeks to months [8, 10]. During clinical recovery, the
alkaline phosphatase rises temporarily due to enhanced
bone formation, after which it normalizes. The relatively
high serum level of 1,25-dihydroxyvitamin D as compared
to 25(OH)D is due to secondary hyperparathyroidism that
causes an enhanced 1α-hydroxylase activity [11].
Response to therapy is illustrated very elegantly in an early
case report by Gershon et al. Symptoms, biochemical markers
ofboneturnover,andbonestructurenormalizedwithinseveral
months after initiating vitamin D therapy, and an electromy-
ography of different muscles improved markedly [9].
This patient illustrates all features of severe osteomala-
cia: a low serum calcium and phosphate, an elevated
alkaline phosphatase, a very low bone mineral density,
signs of bone fissures or pseudofractures on skeletal
scintigraphy, and unsharp milky radiographs with codfish
vertebrae. The bone biopsy showed severe osteomalacia
and secondary hyperparathyroidism. The very low serum
25(OH)D and the severe consequences may also be due to
the fact that she was a non-western immigrant. The latter
group carries a high risk of severe vitamin D deficiency in
the Netherlands as serum 25(OH)D was lower than
25 nmol/L (10 ng/ml) in about half of Turkish and
Moroccan immigrants in a recent survey [23]. The unsharp
delineation of the radiographs is probably due to the very
thick osteoid seams, about seven times the upper limit of
normal. The height loss of the patient may be due to
vertebral height loss. It might partly be reversible since this
is also seen in patients with juvenile osteoporosis.
Our patient had severe mobility problems and muscle
weakness. In order to initiate a quick improvement, she was
treated with calcium infusions since oral calcium would not
be absorbed adequately before healing of the gluten-
sensitive enteropathy. Bone mineralization does not depend
on vitamin D as long as sufficient calcium and phosphate
are available [25]. The therapeutic use of calcium infusions
has been described earlier [1].
Several studies examined bone mineral density in adults
with celiac disease consuming a gluten-free diet. Most studies
show a decrease in BMD which improves when a gluten-free
diet is instituted, but loss of BMD is usually not fully
reversible [4, 12, 15, 16, 21]. Most patients will experience
bone loss due to secondary hyperparathyroidism following
vitamin D deficiency. Another aspect is that that a very low
BMD can indicate osteomalacia as well as osteoporosis.
In celiac disease, osteomalacia should be suspected
when the patient complains of bone pain and muscle
weakness, serum 25(OH)D is very low, and alkaline
phosphatase is elevated. It is seldom the presentation of
an undiagnosed celiac disease. Therapy should be initiated
as soon as possible to prevent bone loss and disability.
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